Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.5K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Hypertension I: Introduction01:28

Hypertension I: Introduction

562
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
562
Obesity01:24

Obesity

1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

162
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
162
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

613
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
613
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

175
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
175

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardiac Amyloidosis: An Updated Review With Emphasis on Diagnosis and Future Directions.

Current problems in cardiology·2017
Same author

Survival of the Fittest-Promoting Fitness Throughout the Life Span.

Mayo Clinic proceedings·2017
Same author

Four Years as Editor-in-Chief.

Progress in cardiovascular diseases·2017
Same author

Vitamin D Metabolism and the Implications for Atherosclerosis.

Advances in experimental medicine and biology·2017
Same author

Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation: A Systematic Review and Meta-analysis of Randomized Controlled Trials.

Current problems in cardiology·2017
Same author

Cardiovascular disease burden in cancer patients from 2003 to 2014.

European heart journal. Quality of care & clinical outcomes·2017

Related Experiment Video

Updated: Dec 21, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

805

Hypertension in obesity.

Michael F Mendoza1, Sergey M Kachur, Carl J Lavie

  • 1Department of Cardiovascular Diseases, John Ochsner Heart and Vascular Institute, Ochsner Clinical School, The University of Queensland School of Medicine, New Orleans, Louisiana, USA.

Current Opinion in Cardiology
|May 14, 2020
PubMed
Summary
This summary is machine-generated.

Obesity significantly contributes to hypertension (HTN), increasing cardiovascular risks. Emerging therapies target underlying mechanisms, offering new hope for managing this widespread health issue.

More Related Videos

Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.6K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.2K

Related Experiment Videos

Last Updated: Dec 21, 2025

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

805
Assessment of Child Anthropometry in a Large Epidemiologic Study
09:36

Assessment of Child Anthropometry in a Large Epidemiologic Study

Published on: February 2, 2017

27.6K
A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats
06:28

A Chronic High-Intensity Interval Training and Diet-Induced Obesity Model to Maximize Exercise Effort and Induce Physiologic Changes in Rats

Published on: April 28, 2023

1.2K

Area of Science:

  • Cardiology
  • Metabolic Disorders
  • Public Health

Background:

  • The global obesity epidemic is a major driver of adverse metabolic and cardiovascular outcomes.
  • Obesity hypertension (HTN) is a growing concern with significant societal implications.

Purpose of the Study:

  • To review the physiology of obesity hypertension.
  • To discuss current and emerging therapeutic options for obesity hypertension.
  • To explore the societal impact of obesity hypertension.

Main Methods:

  • Literature review of physiological mechanisms.
  • Analysis of current and novel therapeutic strategies.
  • Discussion of epidemiological and societal factors.

Main Results:

  • Obesity is the primary cause of hypertension, directly correlated with Body Mass Index (BMI).
  • Adiposity exacerbates HTN through hormonal (renal-angiotensin system, leptin), neural (sympathetic overdrive), and inflammatory pathways, leading to vascular remodeling and cardiovascular disease progression.
  • Newer therapies including carotid baroreflex activation, renal denervation, and leptin receptor antagonism are being developed due to the limitations of current treatments.

Conclusions:

  • The pathophysiology of obesity hypertension requires further elucidation.
  • Continued research is crucial for developing more effective therapeutic options.
  • Addressing obesity hypertension is vital for mitigating cardiovascular disease burden.